shows the newly developed scheme in which
the American Medical
Association
(AMA),
which controls the
standard code set for
the communication of
outpatient and laboratory services between
providers and payers,
has developed more
than 100 new codes for
genetic tests and deleted the former ‘stack
codes’ for molecular
test processes. This
enables an easier pro-
and economically suggests that the idea of
personalised medicine
will eventually become
a regular part of everyday life and therefore both reduce the
costs on the NHS and
improve health conditions or disease awareness of a large majority of the globe.
Patrick Conway, MD,
states that “innovation
gests that personalised
medicine is becoming
gradually more popular and consumers,
although having little
say in health care systems’ protocol, would
surely be for a physician to have access to
a diagnostic test to pick
the right, as opposed
to the wrong, treatment. The maintenance
of wellness for patients
will undoubtedly be
much higher, due to a
larger amount of medi-
The mass progress both medical and economically
suggests that the idea of personalised medicine will
eventually become a regular part of everyday life
cess for both insurance
companies and medical
personnel, which will
aid the transition into
personalised medicine
being global. The mass
progress both medical
is happening broadly across the country.
The promise of personalised medicine and
innovation is amazing,
and we’re already seeing dividends ”. He sug12
cal information for personnel to make decisions regarding both
treatment and diagnosis. Of course, the cost
would be worrying to
the average consumer,